B
Aehr Test Systems AEHR
$36.46 $0.651.82%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)
B
Buy 1/17/2023Upgraded
Aehr Test Systems (AEHR) was upgraded to B- from C+ on 1/17/2023 due to a major increase in the growth index, valuation index and total return index. EBIT increased 660.92% from $458 to $3.49M, earnings per share increased from $0.02 to $0.13, and total revenue increased 38.83% from $10.67M to $14.82M.
C
Hold 1/5/2023Upgraded
Aehr Test Systems (AEHR) was upgraded to C+ from C on 1/5/2023 due to an increase in the valuation index.
C
Hold 11/18/2022Downgrade
Aehr Test Systems (AEHR) was downgraded to C from C+ on 11/18/2022 due to a noticeable decline in the valuation index and total return index.
C
Hold 10/17/2022Downgrade
Aehr Test Systems (AEHR) was downgraded to C+ from B- on 10/17/2022 due to a noticeable decline in the growth index and total return index. EBIT declined 92.13% from $5.82M to $458, earnings per share declined from $0.2054 to $0.02, and total revenue declined 47.4% from $20.29M to $10.67M.
B
Buy 8/29/2022Upgraded
Aehr Test Systems (AEHR) was upgraded to B- from C on 8/29/2022 due to a significant increase in the total return index, efficiency index and growth index. Net income increased 158.31% from $2.24M to $5.79M, EBIT increased 157.98% from $2.26M to $5.82M, and earnings per share increased from $0.08 to $0.2054.
C
Hold 8/18/2022Upgraded
Aehr Test Systems (AEHR) was upgraded to C from C- on 8/18/2022 due to an increase in the total return index and volatility index.
C
Hold 7/28/2022Downgrade
Aehr Test Systems (AEHR) was downgraded to C- from C on 7/28/2022 due to a decline in the volatility index and valuation index.
C
Hold 4/18/2022Upgraded
Aehr Test Systems (AEHR) was upgraded to C from D+ on 4/18/2022 due to a significant increase in the growth index, valuation index and efficiency index. EBIT increased 214.64% from $717 to $2.26M, net income increased 212.83% from $717 to $2.24M, and earnings per share increased from $0.0274 to $0.08.
D
Sell 2/18/2022Downgrade
Aehr Test Systems (AEHR) was downgraded to D+ from C- on 2/18/2022 due to a substantial decline in the total return index and volatility index.
C
Hold 1/14/2022Upgraded
Aehr Test Systems (AEHR) was upgraded to C- from D on 1/14/2022 due to a significant increase in the efficiency index, solvency index and growth index. EBIT increased 172.21% from -$993 to $717, total capital increased 167.43% from $15.8M to $42.24M, and the quick ratio increased from 1.23 to 2.56.
D
Sell 11/23/2021Upgraded
Aehr Test Systems (AEHR) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index and valuation index.
D
Sell 11/8/2021Downgrade
Aehr Test Systems (AEHR) was downgraded to D- from D on 11/8/2021 due to a decline in the valuation index.
D
Sell 2/1/2021Upgraded
Aehr Test Systems (AEHR) was upgraded to D from D- on 2/1/2021 due to an increase in the total return index and volatility index.
D
Sell 1/15/2021Downgrade
Aehr Test Systems (AEHR) was downgraded to D- from D on 1/15/2021 due to a noticeable decline in the growth index, solvency index and total return index. Earnings per share declined from $0.0046 to -$0.084, operating cash flow declined 550.7% from $643 to -$2.9M, and the quick ratio declined from 1.78 to 1.09.
D
Sell 9/2/2020Downgrade
Aehr Test Systems (AEHR) was downgraded to D from D+ on 9/2/2020 due to a significant decline in the growth index and efficiency index. Earnings per share declined from $0.01 to -$0.1251, net income declined 1,277.55% from $245 to -$2.89M, and EBIT declined 1,127.84% from $255 to -$2.62M.
D
Sell 5/20/2020Upgraded
Aehr Test Systems (AEHR) was upgraded to D+ from D on 5/20/2020 due to a major increase in the growth index, efficiency index and solvency index. The quick ratio increased from 1.66 to 2.58, total capital increased 2.49% from $18.51M to $18.97M, and EBIT increased 2% from $250 to $255.
D
Sell 10/15/2018Downgrade
Aehr Test Systems (AEHR) was downgraded to D from D+ on 10/15/2018 due to a noticeable decline in the growth index, efficiency index and total return index. Earnings per share declined from $0.0087 to -$0.07, net income declined 893.19% from $191 to -$1.52M, and EBIT declined 679.12% from $249 to -$1.44M.
D
Sell 8/30/2018Upgraded
Aehr Test Systems (AEHR) was upgraded to D+ from D on 8/30/2018 due to a noticeable increase in the efficiency index, valuation index and solvency index. Debt to equity declined from 0.33 to 0.32, and total capital increased 2.05% from $24.88M to $25.4M.
D
Sell 8/31/2017Upgraded
Aehr Test Systems (AEHR) was upgraded to D from D- on 8/31/2017 due to a significant increase in the growth index, solvency index and total return index. The quick ratio increased from 0.77 to 2.77, total revenue increased 149.27% from $2.68M to $6.68M, and operating cash flow increased 99.12% from -$3.05M to -$27.
D
Sell 3/11/2016Downgrade
Aehr Test Systems (AEHR) was downgraded to D- from D on 3/11/2016 due to a significant decline in the volatility index, total return index and solvency index. Debt to equity increased from 0.71 to 0.81, and the quick ratio declined from 1.2 to 1.07.
D
Sell 4/21/2015Downgrade
Aehr Test Systems (AEHR) was downgraded to D from D+ on 4/21/2015 due to a noticeable decline in the growth index, efficiency index and total return index. Total capital declined 25.97% from $8.14M to $6.02M, total revenue declined 22.49% from $2.62M to $2.03M, and earnings per share declined from -$0.1803 to -$0.14.
D
Sell 10/31/2014Downgrade
Aehr Test Systems (AEHR) was downgraded to D+ from C- on 10/31/2014 due to a decline in the volatility index and valuation index.
C
Hold 10/17/2014Downgrade
Aehr Test Systems (AEHR) was downgraded to C- from C on 10/17/2014 due to a noticeable decline in the volatility index, efficiency index and growth index. EBIT declined 556.81% from $213 to -$973, earnings per share declined from $0.0199 to -$0.08, and net income declined 479.5% from $239 to -$907.
C
Hold 8/29/2014Upgraded
Aehr Test Systems (AEHR) was upgraded to C from C- on 8/29/2014 due to a noticeable increase in the efficiency index, volatility index and valuation index. Total capital increased 15.32% from $6.77M to $7.81M, and net income increased 12.74% from $212 to $239.
C
Hold 6/5/2014Downgrade
Aehr Test Systems (AEHR) was downgraded to C- from C on 6/5/2014 due to a decline in the valuation index.
C
Hold 5/21/2014Upgraded
Aehr Test Systems (AEHR) was upgraded to C from C- on 5/21/2014 due to an increase in the valuation index and volatility index.
C
Hold 4/21/2014Upgraded
Aehr Test Systems (AEHR) was upgraded to C- from D+ on 4/21/2014 due to an increase in the growth index, efficiency index and solvency index. Earnings per share increased from $0.01 to $0.0193, net income increased 54.74% from $137 to $212, and EBIT increased 46.37% from $179 to $262.
Weiss Ratings